| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/29/2007 | CN100333719C Hyperlipemia-treating Chinese traditional medicinal tablet and its preparation process |
| 08/29/2007 | CN100333718C Prepn process of micron Yin-nourishing hypoglycemic medicine granule, capsule and tablet |
| 08/29/2007 | CN100333717C Oral solid dosage of plus color to Rome salts |
| 08/29/2007 | CN100333716C Prepn. process of micron hypoglycemic stomach benefiting health medicine granule, capsule and tablet |
| 08/29/2007 | CN100333715C Magnetic medicinal microball for directional breaking nerve back root and its preparing method |
| 08/29/2007 | CN100333714C Method for producing pellet and pastille |
| 08/29/2007 | CN100333713C Method for preparing milk contg. micron sugared-ginseng and bee-glue for tonifying-Yin and lowering blood-sugar |
| 08/29/2007 | CN100333712C Material gradient controlled-release administrating system and its three-dimensional printing-forming preparation method |
| 08/28/2007 | US7262317 Elastase inhibitor; respiratory system disorders; hypotensive agents; administering by injection |
| 08/28/2007 | US7262221 Hydrophobic core coupled to plurality of hydrophilic moieties that form micelles in solution; encapsulate lipoproteins; atherosclerosis; cardiovascular disorders |
| 08/28/2007 | US7262219 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 08/28/2007 | US7262180 For therapy of dermatitis conditions and skin impairments such as atopic dermatitis, contact dermatitis, allergic contact dermatitis, allergic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of hands or feet, generalized exfoliative dermatitis, stasis dermatitis |
| 08/28/2007 | US7262173 Chemosensitizing with liposomes containing oligonucleotides |
| 08/28/2007 | US7262168 Compositions providing for increased IGF-I solubility |
| 08/28/2007 | US7262165 Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 08/28/2007 | US7261939 Tablets with coloured patterns and preparation thereof |
| 08/28/2007 | US7261907 Administering to an animal subject in need thereof an effective amount of a composition comprising a clathrate of aliphatic material and monoclinic sulfur, wherein the aliphatic material is encapsulated by the monoclinic sulfur |
| 08/28/2007 | US7261903 Infusing a lipid emulsion composition intravenously whereby the anesthetic agent permeates the lipid emulsion composition and is withdrawn from the bloodstream, lipid emulsion comprising soybean oil, an emulsifier, a tonicity modifier, and water |
| 08/28/2007 | US7261896 Methods for preventing strokes by inducing tolerance to e-selectin |
| 08/28/2007 | CA2638668A1 Methods and compositions for treating fish diseases |
| 08/28/2007 | CA2461157C Sustained release heterodisperse hydrogel systems - amorphous drugs |
| 08/28/2007 | CA2450650C Encapsulated cell therapy |
| 08/28/2007 | CA2408776C Process for making personal care compositions comprising titanium dioxide and personal care compositions made by the process |
| 08/28/2007 | CA2405072C Gel compositions containing metronidazole |
| 08/28/2007 | CA2306334C Enteric coated microgranules for stabilizing lactic acid bacteria |
| 08/28/2007 | CA2264693C Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 08/28/2007 | CA2257875C Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders |
| 08/28/2007 | CA2218619C Antibacterial-wound healing compositions and methods for preparing and using same |
| 08/23/2007 | WO2007095347A2 Methods and compositions related to ghs-r antagonists |
| 08/23/2007 | WO2007095156A2 Taste masking of aerosolized fluoroquinolones |
| 08/23/2007 | WO2007095147A2 Adhesive preparation comprising sufentanil and methods of using the same |
| 08/23/2007 | WO2007095043A2 Pharmaceutical formulations |
| 08/23/2007 | WO2007095041A2 Pharmaceutical formulations |
| 08/23/2007 | WO2007094934A1 Radio frequency induced drug elution |
| 08/23/2007 | WO2007094829A2 Isolated and fixed micro and nano structures and methods thereof |
| 08/23/2007 | WO2007094779A1 Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture |
| 08/23/2007 | WO2007094605A1 Topical preparation composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases |
| 08/23/2007 | WO2007094413A1 Medicinal composition for transdermal administration |
| 08/23/2007 | WO2007094385A1 Adhesive patch for external use with improved cohesive force and sustained-release characteristics |
| 08/23/2007 | WO2007094332A1 Disinfectant ointment |
| 08/23/2007 | WO2007094000A2 Applications of microencapsulated essential oils |
| 08/23/2007 | WO2007093999A1 A gastro-retentive system for the delivery of macromolecules |
| 08/23/2007 | WO2007093897A2 Process of making herbal composition with masked bitter taste and product thereof |
| 08/23/2007 | WO2007093853A2 Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols |
| 08/23/2007 | WO2007093808A2 Virucidal materials |
| 08/23/2007 | WO2007093642A2 Microparticulate pharmaceutical forms resistant to immediate release of the active principle in the presence of alcohol |
| 08/23/2007 | WO2007093425A2 Storage-stable oral dosage form of amoxicillin and clavulanic acid |
| 08/23/2007 | WO2007093226A1 Oral ibandronate formulations |
| 08/23/2007 | WO2007093168A2 Rapid release irbesartan-containing pharmaceutical composition |
| 08/23/2007 | WO2007093027A1 Delayed release pharmaceutical oral dosage form and method of making same |
| 08/23/2007 | WO2007092998A1 Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins |
| 08/23/2007 | WO2007073911A3 Masking the taste of powders |
| 08/23/2007 | WO2007070517A3 Fexofenadine suspension formulation |
| 08/23/2007 | WO2007065619A3 Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer |
| 08/23/2007 | WO2007062995A3 Glucan compositions |
| 08/23/2007 | WO2007053179A8 Dry limited use cloth |
| 08/23/2007 | WO2007052042A3 A hollow fibre-based biocompatible drug delivery device with one or more layers |
| 08/23/2007 | WO2007038282A3 Stabilization of clostridium botulinum neurotoxin complex |
| 08/23/2007 | WO2007022165A3 Factor xa inhibitor inclusion complex with cyclodextrin |
| 08/23/2007 | WO2007011875A3 Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders |
| 08/23/2007 | WO2007009726A3 Method for producing pharmaceutical compositions containing glimepiride |
| 08/23/2007 | WO2007007183A3 Compositions of antiviral compound |
| 08/23/2007 | WO2007007182A3 Solid and liquid dosage forms of an antiepileptic agent |
| 08/23/2007 | WO2006132879A3 Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols |
| 08/23/2007 | WO2006126212B1 Epidermal growth factor composition, a process therefor and its application |
| 08/23/2007 | WO2006116565A3 Biodegradable peptide sustained release compositions containing porogens |
| 08/23/2007 | WO2006059141A3 Protein delivery system |
| 08/23/2007 | WO2005123907A3 Ex-vivo application of solid microparticulate therapeutic agents |
| 08/23/2007 | US20070197954 Medical devices with enhanced ultrasonic visibilty |
| 08/23/2007 | US20070197716 Polyethylene compositions and pipe made from same |
| 08/23/2007 | US20070197655 Galenic formulations of organic compounds |
| 08/23/2007 | US20070197648 Pharmaceutical product containing tranilast |
| 08/23/2007 | US20070197637 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits |
| 08/23/2007 | US20070197560 cGMP PDE 5 inhibitors for inhalation in the treatment of sexual dysfunction |
| 08/23/2007 | US20070197503 Solutions containing epinastin |
| 08/23/2007 | US20070197501 Use Of Chemotherapeutic Agents |
| 08/23/2007 | US20070197489 Composition of matter |
| 08/23/2007 | US20070197475 includes rapidly excretable perfluororganic compounds e.g. perfluordecalin, perfluoractilbromide, a perfluoroganic additive embodied in the form of a mixture of perfluorinated tertiary amines contains perfluorotripropylamine and coproducts; and phospholipids in the form of a water-salt dispersion |
| 08/23/2007 | US20070197471 Treatment of degenerative cartilage conditions in a mammal with Glycosidasc Inhibitors |
| 08/23/2007 | US20070197470 Use of n-acetyl-d-aminogylcosamine in preparation of drugs for modulating microorganisms on mucous membrane |
| 08/23/2007 | US20070197468 Oral formulations of cladribine |
| 08/23/2007 | US20070197451 "street-safe" version of a controlled substance such as fentanyl, levorphanol, methadone, oxycodone, morphine, amphetamine, methylphenidate that permits the therapeutically beneficial effects while reducing euphoric effects that lead to substance abuse |
| 08/23/2007 | US20070197437 Compositions for enhanced epithelial permeation of y2 receptor-binding peptides |
| 08/23/2007 | US20070197428 Novel indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals |
| 08/23/2007 | US20070196914 Methods for preparing oil bodies comprising active ingredients |
| 08/23/2007 | US20070196526 Agent for substitution of blood plasma and a method of its production |
| 08/23/2007 | US20070196504 Pharmaceutical composition |
| 08/23/2007 | US20070196503 Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent |
| 08/23/2007 | US20070196502 Flowable particulates |
| 08/23/2007 | US20070196501 Formulations for a tight junction effector |
| 08/23/2007 | US20070196500 Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same |
| 08/23/2007 | US20070196499 Residual Solvent extraction method and microparticles produced thereby |
| 08/23/2007 | US20070196498 Megestrol acetate suspension |
| 08/23/2007 | US20070196497 Pharmaceutical formulations for the prolonged release of active principle(s) and their applications |
| 08/23/2007 | US20070196496 Delivery systems for functional ingredients |
| 08/23/2007 | US20070196495 Method for administering medicaments to subjects with swallowing difficulties and disorders |
| 08/23/2007 | US20070196493 Doxorubicin formulations for anti-cancer use |
| 08/23/2007 | US20070196492 Stimuli-Responesive Hydrogel,Production Method Of Stimuli-Responsive Hydrogel,And Polymer Actuator Using Stimuli-Responsive Hydrogel |
| 08/23/2007 | US20070196491 Drug delivery systems comprising weakly basic drugs and organic acids |
| 08/23/2007 | US20070196490 Method of enhancing needleless transdermal powered drug delivery |